Literature DB >> 32642321

Remote telemedicine evaluation of deep brain stimulation candidacy: Retrospective cohort analysis.

Natalie Witek1, Susan L Heath1, Bichun Ouyang1, Caroline M Tanner1, Nicholas B Galifianakis1.   

Abstract

OBJECTIVE: To determine whether initial presurgical evaluation of deep brain stimulation (DBS) candidacy with video telemedicine (VTEL) can reliably predict surgical candidacy (patients who will eventually undergo DBS surgery) and decrease resource utilization when compared to an in-person evaluation.
METHODS: In this retrospective, cohort analysis, all out-of-state referrals to the San Francisco Veterans Affairs from 2008 to 2013 for DBS therapy were reviewed and their surgical outcomes were assessed until 2017. Patients were designated as good, borderline, or poor surgical candidates after initial evaluation, and their rates of undergoing DBS were recorded. An assessment of patient travel costs was performed.
RESULTS: There were 60 out-of-state DBS referrals identified out of the 148 initial presurgical DBS evaluations completed for surgical treatment of dystonia, essential tremor, or Parkinson disease; 24 patients underwent in-person consultation and 36 patients underwent evaluation via VTEL. There was no difference between the rates of undergoing surgical treatment with DBS based on surgical candidacy for patients in the in-person and VTEL cohorts. Patients who underwent initial presurgical screening via VTEL saved time and money.
CONCLUSIONS: VTEL can be used to facilitate presurgical screening for DBS and saves costs.
© 2019 American Academy of Neurology.

Entities:  

Year:  2020        PMID: 32642321      PMCID: PMC7292554          DOI: 10.1212/CPJ.0000000000000723

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  16 in total

Review 1.  Surgery for movement disorders.

Authors:  W Hu; B T Klassen; M Stead
Journal:  J Neurosurg Sci       Date:  2011-12       Impact factor: 2.279

2.  Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Authors:  A W Willis; M Schootman; B A Evanoff; J S Perlmutter; B A Racette
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

3.  A randomized trial of deep-brain stimulation for Parkinson's disease.

Authors:  Günther Deuschl; Carmen Schade-Brittinger; Paul Krack; Jens Volkmann; Helmut Schäfer; Kai Bötzel; Christine Daniels; Angela Deutschländer; Ulrich Dillmann; Wilhelm Eisner; Doreen Gruber; Wolfgang Hamel; Jan Herzog; Rüdiger Hilker; Stephan Klebe; Manja Kloss; Jan Koy; Martin Krause; Andreas Kupsch; Delia Lorenz; Stefan Lorenzl; H Maximilian Mehdorn; Jean Richard Moringlane; Wolfgang Oertel; Marcus O Pinsker; Heinz Reichmann; Alexander Reuss; Gerd-Helge Schneider; Alfons Schnitzler; Ulrich Steude; Volker Sturm; Lars Timmermann; Volker Tronnier; Thomas Trottenberg; Lars Wojtecki; Elisabeth Wolf; Werner Poewe; Jürgen Voges
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

4.  Utilization of Telemedicine Among Rural Medicare Beneficiaries.

Authors:  Ateev Mehrotra; Anupam B Jena; Alisa B Busch; Jeffrey Souza; Lori Uscher-Pines; Bruce E Landon
Journal:  JAMA       Date:  2016-05-10       Impact factor: 56.272

Review 5.  State of Telehealth.

Authors:  E Ray Dorsey; Eric J Topol
Journal:  N Engl J Med       Date:  2016-07-14       Impact factor: 91.245

6.  Disparities in deep brain stimulation surgery among insured elders with Parkinson disease.

Authors:  Allison W Willis; Mario Schootman; Nathan Kung; Xiao-Yu Wang; Joel S Perlmutter; Brad A Racette
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

7.  Tele-health for patients with deep brain stimulation: The experience of the Ontario Telemedicine Network.

Authors:  Onanong Jitkritsadakul; Rajasumi Rajalingam; Carol Toenjes; Renato P Munhoz; Alfonso Fasano
Journal:  Mov Disord       Date:  2017-11-09       Impact factor: 10.338

8.  Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

Authors:  Günther Deuschl; Michael Schüpbach; Karina Knudsen; Marcus O Pinsker; Philippe Cornu; Jörn Rau; Yves Agid; Carmen Schade-Brittinger
Journal:  Parkinsonism Relat Disord       Date:  2012-07-28       Impact factor: 4.891

9.  Randomized controlled clinical trial of "virtual house calls" for Parkinson disease.

Authors:  E Ray Dorsey; Vinayak Venkataraman; Matthew J Grana; Michael T Bull; Benjamin P George; Cynthia M Boyd; Christopher A Beck; Balaraman Rajan; Abraham Seidmann; Kevin M Biglan
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

Review 10.  The Emerging Evidence of the Parkinson Pandemic.

Authors:  E Ray Dorsey; Todd Sherer; Michael S Okun; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

View more
  5 in total

1.  "Real-Life" Remote Dystonia Assessment: Feasibility, Accuracy, and Practice Implications.

Authors:  Eoin Mulroy; Krista G Sibley; Patricia Limousin; Thomas Foltynie
Journal:  Mov Disord Clin Pract       Date:  2021-08-28

Review 2.  The state of telemedicine for persons with Parkinson's disease.

Authors:  Robin van den Bergh; Bastiaan R Bloem; Marjan J Meinders; Luc J W Evers
Journal:  Curr Opin Neurol       Date:  2021-08-01       Impact factor: 6.283

3.  Success of home-to-home tele-neuropsychology (TeleNP) in deep brain stimulation (DBS) candidacy assessments: COVID-19 and beyond.

Authors:  Marina Sarno; Annelly Buré-Reyes; Scott Harcourt; Ihtsham Haq; Corneliu Luca; Jonathan Jagid; Bonnie Levin
Journal:  Parkinsonism Relat Disord       Date:  2022-04-22       Impact factor: 4.402

4.  The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations.

Authors:  M K York; E Farace; L Pollak; D Floden; G Lin; K Wyman-Chick; J Bobholz; C A Palmese; C Racine; B Tran; T H Turner; J Jimenez-Shahed
Journal:  Parkinsonism Relat Disord       Date:  2021-05-14       Impact factor: 4.891

5.  Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial.

Authors:  Gordon Duffley; Barbara J Lutz; Aniko Szabo; Adrienne Wright; Christopher W Hess; Adolfo Ramirez-Zamora; Pamela Zeilman; Shannon Chiu; Kelly D Foote; Michael S Okun; Christopher R Butson
Journal:  JAMA Neurol       Date:  2021-08-01       Impact factor: 29.907

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.